 - Determine the safety of non-myeloablative allogeneic peripheral blood stem cell transplantation, in terms of regimen-related organ toxicity and toxicity from acute graft-vs-host disease GVHD, in older or medically frail patients with high-risk indolent hematologic malignancies. 